Hosted by NAMEC with guest speakers from McAllister & Quinn and HealthHIV
Description: Medical education companies often rely on pharmaceutical funding, but even in a shifting government environment, funding opportunities in government and foundation sectors remain promising for organizations ready to explore new pathways. These non-commercial funding sources often prioritize impactful education for healthcare professionals and communities that directly improve patient outcomes, creating exciting alignment opportunities for MECCs focused on meaningful educational initiatives.
NAMEC has assembled an expert panel with proven government grant writing experience, foundation funding expertise, and pharmaceutical support backgrounds to explore current government and foundation funding opportunities tailored specifically for medical education companies. This distinguished panel will guide you through today's funding landscape, share successful strategies for competitive applications, and help you build diversified funding portfolios that expand your organization's reach and impact in improving healthcare delivery and patient care.
By the end of this program, participants will be able to:
• Evaluate non-commercial funding landscape including realistic budget forecasts, available funding pools for medical education companies, strategic approaches to foundation versus federal opportunities, and the impact of federal budget cuts on medical education funding
• Conduct a comprehensive organizational readiness assessment to determine internal capacity for grant management
• Identify strategic external partnerships needed to successfully secure and manage government grants
• Apply current best practices for successful grant applications including 2025 updated review criteria, effective proposal language, and strategic relationship building with medical education funders
• Assess grant proposal quality using established success criteria, while implementing post-award compliance requirements and management strategies for successful grant administration
Preliminary Agenda
• Welcome & Introductions
• Understanding the Funding Landscape & Readiness
• Benefits & Considerations of Funding Diversity
• Proposal Development in 2025 and Beyond
• Q&A & Practical Takeaways
Panel Speakers:
HealthHIV

Brian Hujdich
Executive Director, HealthHIV
Marissa Tonelli
Director of Medical Education, HealthHIV
McAllister & Quinn
Andy Quinn
Founding Partner and Managing Partner, McAllister & Quinn
Katherine Williams
Vice President, Advanced Technology
Elaine Meinzer, CRA, MSA
Managing Director, Advance Technology Practice